Filing Details

Accession Number:
0001079973-11-000994
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-15 14:35:36
Reporting Period:
2011-12-13
Filing Date:
2011-12-15
Accepted Time:
2011-12-15 14:35:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1167419 Aspenbio Pharma Inc. APPY In Vitro & In Vivo Diagnostic Substances (2835) 841553387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187604 Jeffrey Mcgonegal C/O Aspenbio Pharma, Inc.
1585 S. Perry Street
Castle Rock CO 80104
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-13 3,625 $1.58 48,431 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,000 Indirect By IRA
Common Stock 300 Indirect By child